Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma
Suayib Yalcin,1 Sahin Lacin21Hacettepe University Institute of Cancer, Department of Medical Oncology, Ankara, Turkey; 2University of Health Sciences, Diyarbakir Gazi Yasargil Training and Research Hospital, Department of Medical Oncology, Diyarbakir, TurkeyCorrespondence: Suayib YalcinHacettepe Uni...
Main Authors: | Yalcin S, Lacin S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-tivozanib-on-patient-outcomes-in-treatment-of-advanced-renal-peer-reviewed-article-CMAR |
Similar Items
-
Tivozanib for the treatment of renal cell carcinoma: patient selection and perspectives
by: Rodenburg RJ, et al.
Published: (2019-05-01) -
Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature
by: Caquelin, L., et al.
Published: (2022) -
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
by: Revati Sharma, et al.
Published: (2021-06-01) -
Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy
by: Bellesoeur A, et al.
Published: (2017-09-01) -
Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
by: Caroline Randrup Hansen, et al.
Published: (2017-02-01)